nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Phosphorus low—Adefovir Dipivoxil—hepatitis B	0.0719	0.108	CcSEcCtD
Temsirolimus—Blood phosphorus decreased—Adefovir Dipivoxil—hepatitis B	0.0571	0.0854	CcSEcCtD
Temsirolimus—Platelet count decreased—Entecavir—hepatitis B	0.0143	0.0214	CcSEcCtD
Temsirolimus—Hypophosphataemia—Adefovir Dipivoxil—hepatitis B	0.0143	0.0213	CcSEcCtD
Temsirolimus—MTOR—blood plasma—hepatitis B	0.0134	0.176	CbGeAlD
Temsirolimus—Skin infection—Lamivudine—hepatitis B	0.013	0.0195	CcSEcCtD
Temsirolimus—FKBP1A—blood plasma—hepatitis B	0.012	0.158	CbGeAlD
Temsirolimus—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0087	0.013	CcSEcCtD
Temsirolimus—Rhabdomyolysis—Telbivudine—hepatitis B	0.00788	0.0118	CcSEcCtD
Temsirolimus—Gingival bleeding—Lamivudine—hepatitis B	0.00693	0.0104	CcSEcCtD
Temsirolimus—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00684	0.0102	CcSEcCtD
Temsirolimus—Folliculitis—Lamivudine—hepatitis B	0.00625	0.00936	CcSEcCtD
Temsirolimus—Sepsis—Telbivudine—hepatitis B	0.00605	0.00906	CcSEcCtD
Temsirolimus—Blood triglycerides increased—Lamivudine—hepatitis B	0.006	0.00898	CcSEcCtD
Temsirolimus—Blood creatinine increased—Entecavir—hepatitis B	0.00577	0.00864	CcSEcCtD
Temsirolimus—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00563	0.00843	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0053	0.00793	CcSEcCtD
Temsirolimus—CYP3A5—blood plasma—hepatitis B	0.00524	0.0689	CbGeAlD
Temsirolimus—Neutropenia—Entecavir—hepatitis B	0.00498	0.00745	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Entecavir—hepatitis B	0.00495	0.00741	CcSEcCtD
Temsirolimus—MTOR—blood—hepatitis B	0.0049	0.0645	CbGeAlD
Temsirolimus—Hyperglycaemia—Entecavir—hepatitis B	0.00481	0.00719	CcSEcCtD
Temsirolimus—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0047	0.00703	CcSEcCtD
Temsirolimus—Acne—Lamivudine—hepatitis B	0.00467	0.00699	CcSEcCtD
Temsirolimus—Renal failure—Entecavir—hepatitis B	0.00467	0.00699	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00456	0.00682	CcSEcCtD
Temsirolimus—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00456	0.00682	CcSEcCtD
Temsirolimus—Haematuria—Entecavir—hepatitis B	0.00453	0.00678	CcSEcCtD
Temsirolimus—Gastritis—Telbivudine—hepatitis B	0.00448	0.0067	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00447	0.00668	CcSEcCtD
Temsirolimus—Rhabdomyolysis—Lamivudine—hepatitis B	0.00444	0.00665	CcSEcCtD
Temsirolimus—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00442	0.00661	CcSEcCtD
Temsirolimus—FKBP1A—blood—hepatitis B	0.00441	0.058	CbGeAlD
Temsirolimus—Abdominal distension—Telbivudine—hepatitis B	0.00441	0.00659	CcSEcCtD
Temsirolimus—Influenza—Telbivudine—hepatitis B	0.00438	0.00655	CcSEcCtD
Temsirolimus—Rectal haemorrhage—Lamivudine—hepatitis B	0.00435	0.00651	CcSEcCtD
Temsirolimus—Viral infection—Lamivudine—hepatitis B	0.00435	0.00651	CcSEcCtD
Temsirolimus—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00435	0.0065	CcSEcCtD
Temsirolimus—CYP3A7—liver—hepatitis B	0.00427	0.0561	CbGeAlD
Temsirolimus—Oedema peripheral—Entecavir—hepatitis B	0.0042	0.00628	CcSEcCtD
Temsirolimus—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00416	0.00622	CcSEcCtD
Temsirolimus—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00413	0.00618	CcSEcCtD
Temsirolimus—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00411	0.00615	CcSEcCtD
Temsirolimus—Neutropenia—Telbivudine—hepatitis B	0.00409	0.00612	CcSEcCtD
Temsirolimus—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00409	0.00612	CcSEcCtD
Temsirolimus—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00408	0.0061	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00407	0.00608	CcSEcCtD
Temsirolimus—CYP3A4—blood plasma—hepatitis B	0.00393	0.0517	CbGeAlD
Temsirolimus—CYP2D6—blood plasma—hepatitis B	0.00387	0.0509	CbGeAlD
Temsirolimus—Immune system disorder—Entecavir—hepatitis B	0.00385	0.00576	CcSEcCtD
Temsirolimus—Renal failure—Telbivudine—hepatitis B	0.00384	0.00574	CcSEcCtD
Temsirolimus—MTOR—liver—hepatitis B	0.00383	0.0504	CbGeAlD
Temsirolimus—Mental disorder—Entecavir—hepatitis B	0.00374	0.00559	CcSEcCtD
Temsirolimus—Malnutrition—Entecavir—hepatitis B	0.00371	0.00555	CcSEcCtD
Temsirolimus—CYP3A7-CYP3A51P—liver—hepatitis B	0.00363	0.0477	CbGeAlD
Temsirolimus—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00362	0.00542	CcSEcCtD
Temsirolimus—Mouth ulceration—Lamivudine—hepatitis B	0.00355	0.00532	CcSEcCtD
Temsirolimus—Back pain—Adefovir Dipivoxil—hepatitis B	0.0035	0.00524	CcSEcCtD
Temsirolimus—Pharyngitis—Telbivudine—hepatitis B	0.00348	0.0052	CcSEcCtD
Temsirolimus—FKBP1A—liver—hepatitis B	0.00345	0.0453	CbGeAlD
Temsirolimus—Connective tissue disorder—Telbivudine—hepatitis B	0.00344	0.00515	CcSEcCtD
Temsirolimus—Sepsis—Lamivudine—hepatitis B	0.00341	0.0051	CcSEcCtD
Temsirolimus—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00335	0.00501	CcSEcCtD
Temsirolimus—Leukopenia—Entecavir—hepatitis B	0.00332	0.00497	CcSEcCtD
Temsirolimus—Cough—Adefovir Dipivoxil—hepatitis B	0.00316	0.00473	CcSEcCtD
Temsirolimus—Mediastinal disorder—Telbivudine—hepatitis B	0.00316	0.00472	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00314	0.0047	CcSEcCtD
Temsirolimus—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00308	0.00461	CcSEcCtD
Temsirolimus—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00308	0.00461	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00306	0.00458	CcSEcCtD
Temsirolimus—Malnutrition—Telbivudine—hepatitis B	0.00305	0.00456	CcSEcCtD
Temsirolimus—Anaphylactic shock—Entecavir—hepatitis B	0.00303	0.00453	CcSEcCtD
Temsirolimus—Infection—Entecavir—hepatitis B	0.00301	0.0045	CcSEcCtD
Temsirolimus—Dysgeusia—Telbivudine—hepatitis B	0.00299	0.00447	CcSEcCtD
Temsirolimus—Nervous system disorder—Entecavir—hepatitis B	0.00297	0.00444	CcSEcCtD
Temsirolimus—Back pain—Telbivudine—hepatitis B	0.00295	0.00441	CcSEcCtD
Temsirolimus—Skin disorder—Entecavir—hepatitis B	0.00294	0.0044	CcSEcCtD
Temsirolimus—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0029	0.00434	CcSEcCtD
Temsirolimus—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00289	0.00433	CcSEcCtD
Temsirolimus—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00287	0.0043	CcSEcCtD
Temsirolimus—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00282	0.00421	CcSEcCtD
Temsirolimus—ABCB1—blood plasma—hepatitis B	0.00278	0.0366	CbGeAlD
Temsirolimus—Insomnia—Entecavir—hepatitis B	0.00274	0.0041	CcSEcCtD
Temsirolimus—Somnolence—Entecavir—hepatitis B	0.00269	0.00403	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00269	0.00403	CcSEcCtD
Temsirolimus—Cough—Telbivudine—hepatitis B	0.00266	0.00398	CcSEcCtD
Temsirolimus—Dehydration—Lamivudine—hepatitis B	0.00265	0.00397	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Entecavir—hepatitis B	0.00262	0.00391	CcSEcCtD
Temsirolimus—Fatigue—Entecavir—hepatitis B	0.00261	0.00391	CcSEcCtD
Temsirolimus—Myalgia—Telbivudine—hepatitis B	0.0026	0.00388	CcSEcCtD
Temsirolimus—Arthralgia—Telbivudine—hepatitis B	0.0026	0.00388	CcSEcCtD
Temsirolimus—Chest pain—Telbivudine—hepatitis B	0.0026	0.00388	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00258	0.00386	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00257	0.00384	CcSEcCtD
Temsirolimus—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00257	0.00384	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00255	0.00382	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00252	0.00377	CcSEcCtD
Temsirolimus—Abdominal distension—Lamivudine—hepatitis B	0.00248	0.00371	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Entecavir—hepatitis B	0.00248	0.00371	CcSEcCtD
Temsirolimus—Influenza—Lamivudine—hepatitis B	0.00247	0.00369	CcSEcCtD
Temsirolimus—Dysphagia—Lamivudine—hepatitis B	0.00247	0.00369	CcSEcCtD
Temsirolimus—Nervous system disorder—Telbivudine—hepatitis B	0.00244	0.00365	CcSEcCtD
Temsirolimus—Thrombocytopenia—Telbivudine—hepatitis B	0.00244	0.00365	CcSEcCtD
Temsirolimus—Skin disorder—Telbivudine—hepatitis B	0.00242	0.00362	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00242	0.00362	CcSEcCtD
Temsirolimus—Body temperature increased—Entecavir—hepatitis B	0.00239	0.00358	CcSEcCtD
Temsirolimus—Abdominal pain—Entecavir—hepatitis B	0.00239	0.00358	CcSEcCtD
Temsirolimus—Bronchitis—Lamivudine—hepatitis B	0.00237	0.00355	CcSEcCtD
Temsirolimus—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00234	0.0035	CcSEcCtD
Temsirolimus—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00234	0.0035	CcSEcCtD
Temsirolimus—Dysuria—Lamivudine—hepatitis B	0.00231	0.00345	CcSEcCtD
Temsirolimus—Neutropenia—Lamivudine—hepatitis B	0.00231	0.00345	CcSEcCtD
Temsirolimus—Pollakiuria—Lamivudine—hepatitis B	0.00228	0.00341	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00227	0.00339	CcSEcCtD
Temsirolimus—Insomnia—Telbivudine—hepatitis B	0.00225	0.00337	CcSEcCtD
Temsirolimus—Hyperglycaemia—Lamivudine—hepatitis B	0.00222	0.00333	CcSEcCtD
Temsirolimus—Depression—Lamivudine—hepatitis B	0.00219	0.00328	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00218	0.00326	CcSEcCtD
Temsirolimus—Asthenia—Entecavir—hepatitis B	0.00217	0.00325	CcSEcCtD
Temsirolimus—Renal failure—Lamivudine—hepatitis B	0.00216	0.00323	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00215	0.00321	CcSEcCtD
Temsirolimus—Fatigue—Telbivudine—hepatitis B	0.00215	0.00321	CcSEcCtD
Temsirolimus—Stomatitis—Lamivudine—hepatitis B	0.00214	0.00321	CcSEcCtD
Temsirolimus—Pain—Telbivudine—hepatitis B	0.00213	0.00318	CcSEcCtD
Temsirolimus—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00212	0.00317	CcSEcCtD
Temsirolimus—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00209	0.00313	CcSEcCtD
Temsirolimus—Epistaxis—Lamivudine—hepatitis B	0.00207	0.0031	CcSEcCtD
Temsirolimus—Diarrhoea—Entecavir—hepatitis B	0.00207	0.0031	CcSEcCtD
Temsirolimus—Sinusitis—Lamivudine—hepatitis B	0.00206	0.00309	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Telbivudine—hepatitis B	0.00203	0.00304	CcSEcCtD
Temsirolimus—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00202	0.00303	CcSEcCtD
Temsirolimus—Dizziness—Entecavir—hepatitis B	0.002	0.003	CcSEcCtD
Temsirolimus—Rhinitis—Lamivudine—hepatitis B	0.00198	0.00296	CcSEcCtD
Temsirolimus—Abdominal pain—Telbivudine—hepatitis B	0.00197	0.00294	CcSEcCtD
Temsirolimus—Body temperature increased—Telbivudine—hepatitis B	0.00197	0.00294	CcSEcCtD
Temsirolimus—Pharyngitis—Lamivudine—hepatitis B	0.00196	0.00293	CcSEcCtD
Temsirolimus—Connective tissue disorder—Lamivudine—hepatitis B	0.00194	0.0029	CcSEcCtD
Temsirolimus—Vomiting—Entecavir—hepatitis B	0.00193	0.00288	CcSEcCtD
Temsirolimus—CYP3A5—blood—hepatitis B	0.00192	0.0252	CbGeAlD
Temsirolimus—Rash—Entecavir—hepatitis B	0.00191	0.00286	CcSEcCtD
Temsirolimus—Dermatitis—Entecavir—hepatitis B	0.00191	0.00285	CcSEcCtD
Temsirolimus—Headache—Entecavir—hepatitis B	0.0019	0.00284	CcSEcCtD
Temsirolimus—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00188	0.00281	CcSEcCtD
Temsirolimus—Erythema multiforme—Lamivudine—hepatitis B	0.00187	0.00279	CcSEcCtD
Temsirolimus—Rash—Adefovir Dipivoxil—hepatitis B	0.00186	0.00279	CcSEcCtD
Temsirolimus—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00186	0.00279	CcSEcCtD
Temsirolimus—Headache—Adefovir Dipivoxil—hepatitis B	0.00185	0.00277	CcSEcCtD
Temsirolimus—Nausea—Entecavir—hepatitis B	0.0018	0.00269	CcSEcCtD
Temsirolimus—Asthenia—Telbivudine—hepatitis B	0.00179	0.00267	CcSEcCtD
Temsirolimus—Immune system disorder—Lamivudine—hepatitis B	0.00178	0.00267	CcSEcCtD
Temsirolimus—Mediastinal disorder—Lamivudine—hepatitis B	0.00178	0.00266	CcSEcCtD
Temsirolimus—Chills—Lamivudine—hepatitis B	0.00177	0.00265	CcSEcCtD
Temsirolimus—Pruritus—Telbivudine—hepatitis B	0.00176	0.00263	CcSEcCtD
Temsirolimus—Nausea—Adefovir Dipivoxil—hepatitis B	0.00176	0.00263	CcSEcCtD
Temsirolimus—Erythema—Lamivudine—hepatitis B	0.00172	0.00257	CcSEcCtD
Temsirolimus—Malnutrition—Lamivudine—hepatitis B	0.00172	0.00257	CcSEcCtD
Temsirolimus—Diarrhoea—Telbivudine—hepatitis B	0.0017	0.00255	CcSEcCtD
Temsirolimus—Dysgeusia—Lamivudine—hepatitis B	0.00168	0.00252	CcSEcCtD
Temsirolimus—Back pain—Lamivudine—hepatitis B	0.00166	0.00249	CcSEcCtD
Temsirolimus—Dizziness—Telbivudine—hepatitis B	0.00165	0.00246	CcSEcCtD
Temsirolimus—Anaemia—Lamivudine—hepatitis B	0.00159	0.00238	CcSEcCtD
Temsirolimus—Vomiting—Telbivudine—hepatitis B	0.00158	0.00237	CcSEcCtD
Temsirolimus—Angioedema—Lamivudine—hepatitis B	0.00157	0.00235	CcSEcCtD
Temsirolimus—Rash—Telbivudine—hepatitis B	0.00157	0.00235	CcSEcCtD
Temsirolimus—Dermatitis—Telbivudine—hepatitis B	0.00157	0.00235	CcSEcCtD
Temsirolimus—Headache—Telbivudine—hepatitis B	0.00156	0.00233	CcSEcCtD
Temsirolimus—Leukopenia—Lamivudine—hepatitis B	0.00154	0.0023	CcSEcCtD
Temsirolimus—CYP3A5—liver—hepatitis B	0.0015	0.0197	CbGeAlD
Temsirolimus—Cough—Lamivudine—hepatitis B	0.0015	0.00224	CcSEcCtD
Temsirolimus—Convulsion—Lamivudine—hepatitis B	0.00149	0.00223	CcSEcCtD
Temsirolimus—Nausea—Telbivudine—hepatitis B	0.00148	0.00221	CcSEcCtD
Temsirolimus—Myalgia—Lamivudine—hepatitis B	0.00146	0.00219	CcSEcCtD
Temsirolimus—Chest pain—Lamivudine—hepatitis B	0.00146	0.00219	CcSEcCtD
Temsirolimus—Arthralgia—Lamivudine—hepatitis B	0.00146	0.00219	CcSEcCtD
Temsirolimus—Anxiety—Lamivudine—hepatitis B	0.00146	0.00218	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00145	0.00217	CcSEcCtD
Temsirolimus—CYP3A4—blood—hepatitis B	0.00144	0.0189	CbGeAlD
Temsirolimus—CYP2D6—blood—hepatitis B	0.00142	0.0186	CbGeAlD
Temsirolimus—Anaphylactic shock—Lamivudine—hepatitis B	0.0014	0.0021	CcSEcCtD
Temsirolimus—Oedema—Lamivudine—hepatitis B	0.0014	0.0021	CcSEcCtD
Temsirolimus—Infection—Lamivudine—hepatitis B	0.00139	0.00208	CcSEcCtD
Temsirolimus—Nervous system disorder—Lamivudine—hepatitis B	0.00138	0.00206	CcSEcCtD
Temsirolimus—Thrombocytopenia—Lamivudine—hepatitis B	0.00137	0.00205	CcSEcCtD
Temsirolimus—Skin disorder—Lamivudine—hepatitis B	0.00136	0.00204	CcSEcCtD
Temsirolimus—Anorexia—Lamivudine—hepatitis B	0.00134	0.002	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00128	0.00191	CcSEcCtD
Temsirolimus—Insomnia—Lamivudine—hepatitis B	0.00127	0.0019	CcSEcCtD
Temsirolimus—Dyspnoea—Lamivudine—hepatitis B	0.00125	0.00187	CcSEcCtD
Temsirolimus—Somnolence—Lamivudine—hepatitis B	0.00125	0.00187	CcSEcCtD
Temsirolimus—Decreased appetite—Lamivudine—hepatitis B	0.00122	0.00182	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00121	0.00181	CcSEcCtD
Temsirolimus—Fatigue—Lamivudine—hepatitis B	0.00121	0.00181	CcSEcCtD
Temsirolimus—Pain—Lamivudine—hepatitis B	0.0012	0.00179	CcSEcCtD
Temsirolimus—Constipation—Lamivudine—hepatitis B	0.0012	0.00179	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Lamivudine—hepatitis B	0.00115	0.00172	CcSEcCtD
Temsirolimus—CYP3A4—liver—hepatitis B	0.00113	0.0148	CbGeAlD
Temsirolimus—CYP2D6—liver—hepatitis B	0.00111	0.0146	CbGeAlD
Temsirolimus—Body temperature increased—Lamivudine—hepatitis B	0.00111	0.00166	CcSEcCtD
Temsirolimus—Abdominal pain—Lamivudine—hepatitis B	0.00111	0.00166	CcSEcCtD
Temsirolimus—Hypersensitivity—Lamivudine—hepatitis B	0.00103	0.00155	CcSEcCtD
Temsirolimus—ABCB1—blood—hepatitis B	0.00102	0.0134	CbGeAlD
Temsirolimus—Asthenia—Lamivudine—hepatitis B	0.00101	0.00151	CcSEcCtD
Temsirolimus—Pruritus—Lamivudine—hepatitis B	0.000992	0.00148	CcSEcCtD
Temsirolimus—Diarrhoea—Lamivudine—hepatitis B	0.00096	0.00144	CcSEcCtD
Temsirolimus—Dizziness—Lamivudine—hepatitis B	0.000927	0.00139	CcSEcCtD
Temsirolimus—Vomiting—Lamivudine—hepatitis B	0.000892	0.00133	CcSEcCtD
Temsirolimus—Rash—Lamivudine—hepatitis B	0.000884	0.00132	CcSEcCtD
Temsirolimus—Dermatitis—Lamivudine—hepatitis B	0.000883	0.00132	CcSEcCtD
Temsirolimus—Headache—Lamivudine—hepatitis B	0.000879	0.00131	CcSEcCtD
Temsirolimus—Nausea—Lamivudine—hepatitis B	0.000833	0.00125	CcSEcCtD
Temsirolimus—ABCB1—liver—hepatitis B	0.000798	0.0105	CbGeAlD
Temsirolimus—Tacrolimus—ALB—hepatitis B	0.000601	1	CrCbGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—hepatitis B	0.000427	0.00167	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—PTEN—hepatitis B	0.000426	0.00167	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—PTEN—hepatitis B	0.000426	0.00167	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—hepatitis B	0.000422	0.00166	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—FAS—hepatitis B	0.00042	0.00165	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000415	0.00163	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000413	0.00162	CbGpPWpGaD
Temsirolimus—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000408	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—hepatitis B	0.000407	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—CTNNB1—hepatitis B	0.000407	0.00159	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—GGT1—hepatitis B	0.000404	0.00158	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000397	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—TNF—hepatitis B	0.000394	0.00155	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000389	0.00153	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000382	0.0015	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DPA1—hepatitis B	0.000382	0.0015	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000377	0.00148	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000368	0.00144	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000363	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—UBE2L3—hepatitis B	0.000362	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD274—hepatitis B	0.000362	0.00142	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TGFB1—hepatitis B	0.000353	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APOBEC3G—hepatitis B	0.000352	0.00138	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SAG—hepatitis B	0.000352	0.00138	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—CTNNB1—hepatitis B	0.00034	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—CDKN1A—hepatitis B	0.000337	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—PTEN—hepatitis B	0.000337	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PDCD1—hepatitis B	0.000331	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—NFKB1—hepatitis B	0.000329	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000327	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—CDKN1A—hepatitis B	0.000323	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—PTEN—hepatitis B	0.000322	0.00126	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.00032	0.00126	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000319	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—CDKN1A—hepatitis B	0.000318	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000317	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—PTEN—hepatitis B	0.000317	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—IL6—hepatitis B	0.000315	0.00124	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNGR1—hepatitis B	0.000308	0.00121	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—IL6—hepatitis B	0.000307	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HSPA5—hepatitis B	0.000306	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—PTEN—hepatitis B	0.000304	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—IL6—hepatitis B	0.000304	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—CDKN1A—hepatitis B	0.000303	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—PTEN—hepatitis B	0.000303	0.00119	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—CDKN1A—hepatitis B	0.000302	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—PTEN—hepatitis B	0.000301	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—PTEN—hepatitis B	0.000301	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—CDKN1A—hepatitis B	0.0003	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—PTEN—hepatitis B	0.0003	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—CDKN1A—hepatitis B	0.000299	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—PTEN—hepatitis B	0.000298	0.00117	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—GOT2—hepatitis B	0.000298	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—IL6—hepatitis B	0.000296	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—IL6—hepatitis B	0.000296	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—hepatitis B	0.000295	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—hepatitis B	0.000294	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—hepatitis B	0.000293	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—hepatitis B	0.000291	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR2—hepatitis B	0.000289	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DPB1—hepatitis B	0.000289	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IFNB1—hepatitis B	0.000287	0.00113	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000287	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CDKN1A—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CDKN1A—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—PTEN—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—PTEN—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000281	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IFNA1—hepatitis B	0.00028	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000279	0.0011	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDKN1A—hepatitis B	0.000279	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—PTEN—hepatitis B	0.000278	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1A—hepatitis B	0.000276	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—PTEN—hepatitis B	0.000276	0.00108	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000275	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CDKN1A—hepatitis B	0.000275	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—PTEN—hepatitis B	0.000274	0.00108	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—IL6—hepatitis B	0.000266	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MX1—hepatitis B	0.000264	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—IL6—hepatitis B	0.000262	0.00103	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD14—hepatitis B	0.000261	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IFNA2—hepatitis B	0.000261	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CDKN1A—hepatitis B	0.00026	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—PTEN—hepatitis B	0.00026	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—NFKB1—hepatitis B	0.000258	0.00101	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—GOT1—hepatitis B	0.000257	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN2A—hepatitis B	0.00025	0.00098	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000249	0.000977	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000249	0.000975	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—IL6—hepatitis B	0.000248	0.000971	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RIT2—hepatitis B	0.000247	0.000968	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SAG—hepatitis B	0.000247	0.000968	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—IL6—hepatitis B	0.000246	0.000964	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000245	0.00096	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.00024	0.000943	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000217	0.000853	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000215	0.000843	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD40LG—hepatitis B	0.000213	0.000835	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKR1B1—hepatitis B	0.000211	0.000826	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD8A—hepatitis B	0.000211	0.000826	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—IL6—hepatitis B	0.00021	0.000825	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000207	0.000813	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1A—hepatitis B	0.000204	0.000801	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—NFKB1—hepatitis B	0.000203	0.000796	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GGT2—hepatitis B	0.000202	0.000792	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000201	0.000789	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—IL6—hepatitis B	0.000198	0.000777	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CCR5—hepatitis B	0.000192	0.000752	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1A—hepatitis B	0.000192	0.000752	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PTEN—hepatitis B	0.000191	0.00075	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000191	0.000749	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—NFKB1—hepatitis B	0.00019	0.000746	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—IL6—hepatitis B	0.000189	0.000742	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—IL6—hepatitis B	0.000188	0.000738	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-A—hepatitis B	0.000188	0.000736	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000188	0.000736	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—IL6—hepatitis B	0.000187	0.000735	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HLA-A—hepatitis B	0.000187	0.000733	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—IL6—hepatitis B	0.000186	0.000731	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HSPA5—hepatitis B	0.000185	0.000728	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—TLR4—hepatitis B	0.000179	0.000701	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000178	0.0007	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000175	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—IL6—hepatitis B	0.000175	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—IL6—hepatitis B	0.000175	0.000688	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DPB1—hepatitis B	0.000175	0.000687	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—IL6—hepatitis B	0.000174	0.000682	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL10—hepatitis B	0.000173	0.000679	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000172	0.000676	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000171	0.000673	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—IL6—hepatitis B	0.000171	0.000673	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR2—hepatitis B	0.000169	0.000661	CbGpPWpGaD
Temsirolimus—MTOR—Disease—GOT2—hepatitis B	0.000167	0.000657	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNB1—hepatitis B	0.000167	0.000656	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNA1—hepatitis B	0.000163	0.00064	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—NOS2—hepatitis B	0.000163	0.000638	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000155	0.000609	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKR1B1—hepatitis B	0.000152	0.000597	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNA2—hepatitis B	0.000152	0.000596	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD14—hepatitis B	0.000152	0.000596	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GGT2—hepatitis B	0.000146	0.000573	CbGpPWpGaD
Temsirolimus—MTOR—Disease—GOT1—hepatitis B	0.000144	0.000567	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—hepatitis B	0.000139	0.000546	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCR5—hepatitis B	0.000134	0.000527	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL18—hepatitis B	0.00013	0.000509	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD40LG—hepatitis B	0.000129	0.000507	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD8A—hepatitis B	0.000128	0.000501	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—IL6—hepatitis B	0.000127	0.000499	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CD4—hepatitis B	0.000126	0.000494	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CYP2A6—hepatitis B	0.000122	0.00048	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CD4—hepatitis B	0.000121	0.000474	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CD4—hepatitis B	0.00012	0.000472	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—IL6—hepatitis B	0.000119	0.000468	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000117	0.000458	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—F2—hepatitis B	0.000115	0.000452	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKR1B1—hepatitis B	0.000115	0.000451	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000114	0.000447	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-A—hepatitis B	0.000114	0.000447	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000114	0.000446	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000113	0.000444	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CTNNB1—hepatitis B	0.000112	0.000439	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GOT2—hepatitis B	0.000111	0.000434	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GGT2—hepatitis B	0.00011	0.000432	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1A—hepatitis B	0.000109	0.000429	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PTEN—hepatitis B	0.000109	0.000428	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—NFKB1—hepatitis B	0.000109	0.000426	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKR1B1—hepatitis B	0.000108	0.000425	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CCR5—hepatitis B	0.000108	0.000423	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CTNNB1—hepatitis B	0.000107	0.00042	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HLA-A—hepatitis B	0.000105	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1A—hepatitis B	0.000105	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PTEN—hepatitis B	0.000105	0.000411	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1A—hepatitis B	0.000104	0.00041	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTEN—hepatitis B	0.000104	0.000409	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—NFKB1—hepatitis B	0.000104	0.000409	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—TLR4—hepatitis B	0.000104	0.000408	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HLA-DRB1—hepatitis B	0.000104	0.000408	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GGT2—hepatitis B	0.000104	0.000407	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL10—hepatitis B	9.74e-05	0.000382	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GGT1—hepatitis B	9.55e-05	0.000375	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GOT1—hepatitis B	9.55e-05	0.000375	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	9.42e-05	0.00037	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOS2—hepatitis B	9.14e-05	0.000359	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2A6—hepatitis B	8.84e-05	0.000347	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	8.8e-05	0.000345	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—hepatitis B	8.64e-05	0.000339	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GOT2—hepatitis B	8e-05	0.000314	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—hepatitis B	7.76e-05	0.000304	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	7.76e-05	0.000304	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—hepatitis B	7.6e-05	0.000298	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCR5—hepatitis B	7.55e-05	0.000296	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CTNNB1—hepatitis B	7.49e-05	0.000294	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD4—hepatitis B	7.34e-05	0.000288	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1A—hepatitis B	7.32e-05	0.000287	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTEN—hepatitis B	7.3e-05	0.000286	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—NFKB1—hepatitis B	7.27e-05	0.000285	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKR1B1—hepatitis B	7.08e-05	0.000278	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GGT1—hepatitis B	6.9e-05	0.000271	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GOT1—hepatitis B	6.9e-05	0.000271	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—IL6—hepatitis B	6.81e-05	0.000267	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GGT2—hepatitis B	6.79e-05	0.000266	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD4—hepatitis B	6.77e-05	0.000266	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—hepatitis B	6.75e-05	0.000265	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2A6—hepatitis B	6.67e-05	0.000262	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTNNB1—hepatitis B	6.52e-05	0.000256	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—IL6—hepatitis B	6.51e-05	0.000255	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—F2—hepatitis B	6.48e-05	0.000254	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1A—hepatitis B	6.36e-05	0.00025	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTEN—hepatitis B	6.35e-05	0.000249	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—NFKB1—hepatitis B	6.32e-05	0.000248	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2A6—hepatitis B	6.29e-05	0.000247	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—hepatitis B	6.05e-05	0.000237	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GOT2—hepatitis B	6.03e-05	0.000237	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CTNNB1—hepatitis B	6.02e-05	0.000236	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	5.92e-05	0.000232	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1A—hepatitis B	5.88e-05	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTEN—hepatitis B	5.86e-05	0.00023	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GOT2—hepatitis B	5.69e-05	0.000223	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GGT1—hepatitis B	5.21e-05	0.000204	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GOT1—hepatitis B	5.21e-05	0.000204	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ALB—hepatitis B	5.08e-05	0.000199	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—hepatitis B	4.98e-05	0.000195	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GOT1—hepatitis B	4.91e-05	0.000193	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GGT1—hepatitis B	4.91e-05	0.000193	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—hepatitis B	4.86e-05	0.000191	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL6—hepatitis B	4.56e-05	0.000179	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—hepatitis B	4.36e-05	0.000171	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CTNNB1—hepatitis B	4.21e-05	0.000165	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1A—hepatitis B	4.12e-05	0.000161	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2A6—hepatitis B	4.11e-05	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTEN—hepatitis B	4.11e-05	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NFKB1—hepatitis B	4.09e-05	0.00016	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL6—hepatitis B	3.97e-05	0.000156	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTEN—hepatitis B	3.88e-05	0.000152	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GOT2—hepatitis B	3.72e-05	0.000146	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ALB—hepatitis B	3.67e-05	0.000144	CbGpPWpGaD
Temsirolimus—MTOR—Disease—IL6—hepatitis B	3.66e-05	0.000144	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—hepatitis B	3.4e-05	0.000134	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GOT1—hepatitis B	3.21e-05	0.000126	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GGT1—hepatitis B	3.21e-05	0.000126	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—hepatitis B	2.8e-05	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTEN—hepatitis B	2.8e-05	0.00011	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—ALB—hepatitis B	2.77e-05	0.000109	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ALB—hepatitis B	2.61e-05	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL6—hepatitis B	2.56e-05	0.000101	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTEN—hepatitis B	2.11e-05	8.29e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTEN—hepatitis B	1.99e-05	7.81e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ALB—hepatitis B	1.71e-05	6.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTEN—hepatitis B	1.3e-05	5.11e-05	CbGpPWpGaD
